Fig. 4From: NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agentsNSD1 mutations are enriched in HPV(−) laryngeal tumors. (a) Percentage by subsite of HPV(−) tumors (n = 457) in expanded TCGA cohort. (b) Percentage of NSD1 mutations (n = 60) in HPV(−) tumors, grouped by subsiteBack to article page